, /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast: INVESTOR CONTACT:                      MEDIA CONTACT: Jim Lucas   Danielle Canzanella Direct: 414.340.1752                        Direct: 414.524.8687 Email: [email protected]                      Email: [email protected] What: Johnson Controls Fourth Quarter Fiscal 2025 Earni ...

SOURCE Locksley Resources WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? , /PRNewswire/ -- Locksley Resources, (ASX: LKY;Â OTCQB: LKYRF) announced that the company's advancing metallurgical test work program being conducted on surface samples collected from the Desert Antimony Mine (DAM) Prospect at the company's project in the Mojave Desert is producing concentrate grades believed to be significantly higher than comparable American projects (as reported in publicly available information from Perpetua ...

Quad (NYSE: QUAD) is a marketing experience, or MX, company that helps brands make direct consumer connections, from household to in-store to online. The company does this through its MX Solutions Suite, a comprehensive range of marketing and print services that seamlessly integrate creative, production and media solutions across online and offline channels. Supported by state-of-the-art technology and data-driven intelligence, Quad simplifies the complexities of marketing by removing friction wherever it o ...

, /PRNewswire/ -- 1919 Investment Counsel, LLC ("1919"), a subsidiary of Stifel Financial Corp. ("Stifel"), is pleased to announce the hiring of Braxton Comer as a Principal, Business Development Officer. Braxton brings a dynamic blend of strategic insight and legal expertise to the firm. He began his career at Accenture LLP in Atlanta, where he focused on delivering strategic solutions for a global client base. Following his time in consulting, Braxton earned his law degree from The University of Alabama S ...

The collaboration integrates VisionWave's advanced radar and AI-driven computer vision systems with PVML's secure, real-time data-AI infrastructure, connecting live defense data sources directly to active mission environments. This combination seeks to enable the development of an operational system powered by thousands of autonomous AI agents that plan missions, track execution, and respond dynamically to real-time deviations. Early joint projects suggest that development cycles can be reduced by up to 70% ...

, /PRNewswire/ - Galiano Gold Inc. ("Galiano" or the "Company") (TSX: GAU) (NYSE American: GAU) is pleased to announce it will release its third quarter ("Q3") 2025 financial and operational results after market close on November 6, 2025. The Company will host a conference call and webcast to review and discuss the Q3 results on November 7, 2025, at 7:30am PT. Conference Call Details Replay (available until November 14, 2025) | Date: | November 7, 2025 | Local: | 289-819-1450 | | --- | --- | --- | --- | | ...

-INSIDE, the Company's technology media brand, will host its flagship annual forum INSIDE Future Day 2025 on December 9, 2025 in Taipei -The event focuses on emerging trends in technology and innovation and brings together key figures from the tech industry, including entrepreneurs, investors and senior executives, to share their insights and experiences on future technologies, industry shifts and startup trends -The forum theme "Next-Gen AI Agents: Building a New Era of Human-AI Collaboration" underscores ...

If you are a KinderCare investor and would like to learn more about this action, CLICK HERE  or please contact Berger Montague: Andrew Abramowitz at [email protected] or (215) 875-3015, or Caitlin Adorni at [email protected] or (267)764-4865. About Berger Montague Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto, has been a pioneer in securities class action litigation since its founding in 1970. Berger Mo ...

Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS , /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced the first patient has been enrolled in the dose expansion phase of the ongoing Phase 1b study of R289 in patients with relapsed or refractory (R/R) lower-risk myelodysplastic syndrome (MDS). R289 is Rigel's potent a ...

公司与英伟达的合作协议 - Hoth Therapeutics公司获得英伟达AI Enterprise Essentials年度订阅许可，以支持其GPU驱动的基础设施[1][2] - 该协议旨在加速数据驱动的药物开发、临床前建模和预测分析[1] - 公司CEO表示，持续投资英伟达AI平台反映了其将下一代技术整合到研发项目中的长期承诺[3] AI技术应用与研发加速 - 英伟达AI Enterprise环境将赋能公司的科学和数据团队部署预测药理学和毒性模型，以提高化合物筛选效率[6] - 该环境将整合多组学和患者衍生数据，以改进靶点发现[6] - 该环境还将支持临床试验模拟、患者分层和实时反应监测[6] - 公司将利用具备企业级可靠性和合规性的安全GPU加速云基础设施[6] 公司战略与业务重点 - Hoth Therapeutics是一家临床阶段生物制药公司，专注于开发针对皮肤病和肿瘤疾病的创新疗法[1][4] - 公司的AI计划是其生物技术领域数字化转型和创新更广泛战略的一部分[3] - 该战略旨在通过与先进的AI驱动平台和生命科学数据公司合作，优化开发时间表、降低成本并改善治疗结果[3] - 公司致力于利用以患者为中心的方法，与科学家、临床医生和关键意见领袖合作，寻求和研究具有巨大潜力的治疗方法[4]